Loss of a newly discovered microRNA in Chinese hamster ovary cells leads to upregulation of N-glycolylneuraminic acid sialylation on monoclonal antibodies.


Journal

Biotechnology and bioengineering
ISSN: 1097-0290
Titre abrégé: Biotechnol Bioeng
Pays: United States
ID NLM: 7502021

Informations de publication

Date de publication:
03 2022
Historique:
revised: 10 12 2021
received: 07 06 2021
accepted: 11 12 2021
pubmed: 23 12 2021
medline: 5 4 2022
entrez: 22 12 2021
Statut: ppublish

Résumé

Chinese hamster ovary (CHO) cells are known not to express appreciable levels of the sialic acid residue N-glycolylneuraminic acid (NGNA) on monoclonal antibodies. However, we actually have identified a recombinant CHO cell line expressing an IgG with unusually high levels of NGNA sialylation (>30%). Comprehensive multi-OMICs based experimental analyses unraveled the root cause of this atypical sialylation: (1) expression of the cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) gene was spontaneously switched on, (2) CMAH mRNA showed an anti-correlated expression to the newly discovered Cricetulus griseus (cgr) specific microRNA cgr-miR-111 and exhibits two putative miR-111 binding sites, (3) miR-111 expression depends on the transcription of its host gene SDK1, and (4) a single point mutation within the promoter region of the sidekick cell adhesion molecule 1 (SDK1) gene generated a binding site for the transcriptional repressor histone H4 transcription factor HINF-P. The resulting transcriptional repression of SDK1 led to a downregulation of its co-expressed miR-111 and hence to a spontaneous upregulation of CMAH expression finally increasing NGNA protein sialylation.

Identifiants

pubmed: 34935124
doi: 10.1002/bit.28015
pmc: PMC9306616
doi:

Substances chimiques

Antibodies, Monoclonal 0
MicroRNAs 0
Neuraminic Acids 0
Recombinant Proteins 0
N-glycolylneuraminic acid 1113-83-3
N-Acetylneuraminic Acid GZP2782OP0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

832-844

Informations de copyright

© 2021 Boehringer Ingelheim Pharma GmbH & Co.KG. Biotechnology and Bioengineering published by Wiley Periodicals LLC.

Références

J Immunol Methods. 2016 Jan;428:30-6
pubmed: 26627984
Curr Opin Neurobiol. 1999 Feb;9(1):79-87
pubmed: 10072367
Biotechnol J. 2018 Mar;13(3):e1700234
pubmed: 29316325
MAbs. 2010 Sep-Oct;2(5):466-79
pubmed: 20622510
Curr Opin Biotechnol. 2009 Dec;20(6):700-7
pubmed: 19889531
Nature. 2007 Apr 26;446(7139):1023-9
pubmed: 17460663
Appl Microbiol Biotechnol. 2012 May;94(4):887-905
pubmed: 22526796
Methods Mol Biol. 2017;1603:25-44
pubmed: 28493121
Nat Biotechnol. 2010 Aug;28(8):863-7
pubmed: 20657583
Cell. 2020 Apr 30;181(3):520-535
pubmed: 32359436
J Pharm Sci. 2019 Apr;108(4):1366-1377
pubmed: 30471292
Annu Rev Cell Dev Biol. 2009;25:161-95
pubmed: 19575668
Curr Pharm Biotechnol. 2010 Apr;11(3):233-40
pubmed: 20210750
Genome Biol. 2014;15(12):550
pubmed: 25516281
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
J Immunol. 2017 Mar 15;198(6):2366-2373
pubmed: 28148732
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92
pubmed: 31701148
Biotechnol Adv. 2015 Dec;33(8):1878-96
pubmed: 26523782
Cell. 2002 Sep 6;110(5):649-60
pubmed: 12230981
Nat Biotechnol. 2006 Oct;24(10):1241-52
pubmed: 17033665
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12045-50
pubmed: 14523234
Leukemia. 2010 Nov;24(11):1834-43
pubmed: 20861919
Glycobiology. 2009 Sep;19(9):936-49
pubmed: 19494347
J Biol Chem. 2001 Jun 15;276(24):21656-63
pubmed: 11283023
Gene. 2011 Sep 1;483(1-2):1-10
pubmed: 21605641
Biotechnol Bioeng. 2022 Mar;119(3):832-844
pubmed: 34935124
FEBS Lett. 1990 Nov 26;275(1-2):9-14
pubmed: 2124546
Mol Cell Biol. 2004 Oct;24(20):8803-12
pubmed: 15456856
Elife. 2016 Sep 19;5:
pubmed: 27644106
Nucleic Acids Res. 2013 Jan;41(2):727-37
pubmed: 23221645
Dev Biol. 2003 Dec 1;264(1):240-54
pubmed: 14623245
Genome Res. 2017 May;27(5):824-834
pubmed: 28298430
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
J Pharm Sci. 2009 Oct;98(10):3499-508
pubmed: 19199295
J Biotechnol. 2013 Dec;168(4):589-600
pubmed: 23994267
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Biotechnol. 2013 Aug;31(8):694-5
pubmed: 23929341
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Nat Biotechnol. 2011 Jul 31;29(8):735-41
pubmed: 21804562
Nat Biotechnol. 1996 Aug;14(8):975-81
pubmed: 9631034
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11751-6
pubmed: 9751737
Biotechnol Bioeng. 2018 Jun;115(6):1378-1393
pubmed: 29457629
Appl Microbiol Biotechnol. 2005 Aug;68(3):283-91
pubmed: 15834715
Front Mol Neurosci. 2020 Aug 25;13:139
pubmed: 32982686
Proc Natl Acad Sci U S A. 2009 Jul 28;106(30):12359-64
pubmed: 19590016
Cytokine Growth Factor Rev. 2013 Apr;24(2):123-31
pubmed: 23102646
Elife. 2015 Aug 12;4:
pubmed: 26267216

Auteurs

Simon Fischer (S)

Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.

Sven Mathias (S)

Early Stage Bioprocess Development, Bioprocess Development Biologicals, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.
Institute of Applied Biotechnology, University of Applied Sciences, Biberach, Germany.

Anna Stadermann (A)

Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.

Shumin Yang (S)

Process Science, Boehringer Ingelheim Fremont Inc., Fremont, California, USA.

Valerie Schmieder (V)

Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.

Nikolas Zeh (N)

Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.

Nicoletta Schmidt (N)

Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.

Patrick Richter (P)

Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.

Sara Wright (S)

Analytical Science, Boehringer Ingelheim Fremont Inc., Fremont, California, USA.

Eike Zimmermann (E)

Analytical Science, Boehringer Ingelheim Fremont Inc., Fremont, California, USA.

Yan Ley (Y)

Analytical Science, Boehringer Ingelheim Fremont Inc., Fremont, California, USA.

Julia van der Meer (J)

Genedata AG, Basel, Switzerland.

Thomas Hartsch (T)

Genedata AG, Basel, Switzerland.

Christian Bernloehr (C)

Early Stage Bioprocess Development, Bioprocess Development Biologicals, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.

Kerstin Otte (K)

Institute of Applied Biotechnology, University of Applied Sciences, Biberach, Germany.

Harald Bradl (H)

Protein Science, Bioprocess & Analytical Development, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.

Martin Gamer (M)

Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.

Patrick Schulz (P)

Cell Line Development, Bioprocess Development Biologicals, Boehringer Ingelheim GmbH & Co. KG, Biberach, Germany.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH